Date: September 18th, 2019
Reference: Scheuermeyer et al. A Multicenter Randomized Trial to Evaluate a Chemical-first Cardioversion Strategy for Patients with Uncomplicated Acute Atrial Fibrillation. AEM Sept 2019
Guest Skeptic: Dr. Chris Bond is an emergency medicine physician and clinical lecturer in Calgary. He is also an avid FOAM supporter/producer through various online outlets including …